Insider TradingAug 4, 2026, 07:07 AM
Tiziana Life Sciences CEO Increases Shareholding by 667,000 Shares
AI Summary
Tiziana Life Sciences Ltd announced that its Chief Executive Officer, Ivor Elrifi, increased his stake in the company. He purchased 667,000 common shares on NASDAQ at $1.00 per share. This transaction brings his total ownership to 4,472,261 common shares, demonstrating increased confidence in the company.
Key Highlights
- Tiziana Life Sciences CEO, Ivor Elrifi, purchased 667,000 common shares.
- The shares were acquired on NASDAQ at a price of $1.00 per share.
- This purchase increases his total holding to 4,472,261 common shares.
Price Impact
More from TLSA